Navigation Links
Shimadzu and EDDA Announce Business Partnership on X-ray Chest CAD Applications

KYOTO, Japan and PRINCETON, N.J., Nov. 11 /PRNewswire/ -- Shimadzu Corporation (Kyoto Japan) and EDDA Technology Inc. (Princeton, NJ, USA) today announced that both parties have entered into a business partnership on X-ray chest CAD systems based on the Radiography System of Shimadzu featuring its direct conversion flat panel detector (FPD) and EDDA's CAD applications.

This partnership contains both distribution of EDDA's chest X-ray CAD applications with Shimadzu's DR system through Shimadzu's worldwide sales channel and the development of fully new applications integrating Shimadzu's state-of-the-art application for digital radiography together with EDDA's sophisticated technology in the field of chest CAD.

Chest X-ray CAD (Computer Aided Detection) is an advanced clinical application aiming the improvement of physician's detection accuracy of lung nodules by identifying possible nodules efficiently using computer image analysis technology, which will also help to overcome the challenge of workload of physicians in the diagnosis process. Chest X-ray is the most commonly performed radiographic exam accounting for nearly 50% of all imaging tests, and over 70 million chest X-rays are performed yearly in the US.

EDDA is a pioneer in the area of chest CAD application. Its IQQA®-Chest CAD product is already approved by FDA, EU CE and China SFDA, and is sold and used in USA, Europe, China and other countries. The first prospective study on chest X-ray CAD published in peer-reviewed journal showed positive results that suggest the interpretation of chest radiographs for lung nodules can be improved using IQQA®-Chest. Shimadzu will distribute this chest X-ray CAD application with its DR products in worldwide markets (*). Both companies are working together to prepare another innovative new chest CAD application which shall be introduced to worldwide markets in the upcoming years.

"According to the statistics such as those from WHO, ratio of death from cancer in the recent years tends to be decreasing. However, that from lung cancer is remarkably increasing, " said Mr. Kunimasa Itoh, general manager, marketing dept., medical systems division of Shimadzu Corporation. "Through the partnership with EDDA, who is expert of application development in this field, we will be able to contribute to improving clinical workflow and quality care of patients by providing advanced image diagnosis solutions to aid in early detection of lung lesions."

"Our partnership with Shimadzu Corporation reflects the increasingly important role that advanced computer application plays in enhancing clinical workflow to be faster, better and more cost-effective," said Dr. Jian-Zhong Qian, president and CEO of EDDA Technology. "We are pleased to partner with Shimadzu to offer new solutions to the diagnosis and management of potentially life-threatening lung diseases."

(* Regulatory approval for the distribution through Shimadzu in Japan and other countries are pending as of this moment.)

About Shimadzu Corporation

Founded in 1875, Shimadzu Corporation, a leader in the development of advanced technologies, has a distinguished history of innovation build on the foundation of contributing to society through science and technology. Shimadzu maintain a global network of sales, service, technical support and applications centers on six continents, and have established long-term relationship with a host of highly trained distributors located in over 100 countries.

About EDDA Technology

EDDA Technology, Inc. is an innovative clinical computer solution provider in diagnostic imaging and analysis. EDDA offers a series of new generation software products to enable early detection of diseases, and enhance efficiency and precision in diagnosis and treatment. EDDA's goal is to deliver, with broad accessibility, advanced information analysis technologies that improve clinical workflow and accuracy. A privately held Delaware corporation, EDDA is headquartered in Princeton, New Jersey, and has a subsidiary in Shanghai, China. IQQA is a registered trademark of EDDA Technology.

Editor's Note: EDDA Technology will be exhibiting in Booth # 9318, and Shimadzu Corporation in Booth #5000, of McCormick Place in Chicago at the 95th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA), Nov. 29 - Dec. 3, 2009.

SOURCE Edda Technology, Inc.

SOURCE Edda Technology, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
5. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
6. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
7. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
8. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
9. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
10. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
11. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
Post Your Comments:
(Date:11/25/2015)... 25, 2015 Allergan plc (NYSE: ... Rugen Therapeutics, a start-up  biotechnology company focused on ... disorders and funded by the F-Prime Biomedical Research ... into an exclusive collaboration to support the discovery ... Disorders (ASD) and Obsessive Compulsive disorders (OCD). ...
(Date:11/25/2015)... 2015 USP 800 applies to all ... pharmacists, pharmacy technicians, nurses, physicians, physician assistants, home ... also covers all entities which store, prepare, transport, ... healthcare institutions, patient treatment clinics, physicians, practice facilities, ... --> What is the purpose of ...
(Date:11/25/2015)... 2015 Asia -based ... BioLight and the New Investors will make a direct ... a private placement. The financing will help IOPtima to ... used in the treatment of glaucoma, as well as ... IOPtimate™ system with the U.S. Food and Drug Administration, ...
Breaking Medicine Technology:
(Date:11/25/2015)... ... November 25, 2015 , ... Finnleo, a leader in the traditional ... models of traditional and far-infrared saunas. , For traditional saunas, Finnleo is ... traditional Finnish sauna wood, and Finnleo uses only European Grade A Nordic White Spruce ...
(Date:11/25/2015)... ... 26, 2015 , ... Ministers, senior government and UN agencies, ... Centres of Excellence, and public R&D institutions, civil societies and other partners gathered ... 5th African Network for Drugs and Diagnostics Innovation, ANDI, Stakeholders Meeting. The three- ...
(Date:11/25/2015)... ... November 25, 2015 , ... Lakeview Health, a Jacksonville-based drug ... their sobriety and show through pictures what a positive difference it makes. The ... with the hashtag #FacesOfGratitude on their Facebook, Twitter, and Instagram accounts. Short ...
(Date:11/25/2015)... ... November 25, 2015 , ... The McHenry County law firm of ... decision obtained by Attorneys Francisco J. Botto and Alex C. Wimmer. Attorneys Botto and ... Comm’n, 2015 IL App (2d) 130884WC. , According to court documents, Adcock testified that ...
(Date:11/25/2015)... (PRWEB) , ... November 25, 2015 , ... Beddit® has ... Beddit Classic sleep tracking systems. The new app features a more intuitive SleepScore™ that ... understand how well you slept. The SleepScore is created by a proprietary algorithm. Beddit ...
Breaking Medicine News(10 mins):